NCT01948622View on ClinicalTrials.gov

Anxiety Control by Erythrina Mulungu

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

November 30, 2012

Conditions
Dental AnxietyImpacted Third Molar Tooth
Interventions
DRUG

Mulungu

500 mg/single dose/1 hour before dental surgery

DRUG

Placebo

500 mg/single dose/1 hour before dental surgery

Trial Locations (1)

49060-100

Federal University of Sergipe, Aracaju

All Listed Sponsors
collaborator

University of Campinas, Brazil

OTHER

lead

Liane Maciel de Almeida Souza

OTHER

NCT01948622 - Anxiety Control by Erythrina Mulungu | Biotech Hunter | Biotech Hunter